These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18523133)

  • 1. Elevated glutathione levels confer cellular sensitization to cisplatin toxicity by up-regulation of copper transporter hCtr1.
    Chen HH; Song IS; Hossain A; Choi MK; Yamane Y; Liang ZD; Lu J; Wu LY; Siddik ZH; Klomp LW; Savaraj N; Kuo MT
    Mol Pharmacol; 2008 Sep; 74(3):697-704. PubMed ID: 18523133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated GSH level increases cadmium resistance through down-regulation of Sp1-dependent expression of the cadmium transporter ZIP8.
    Aiba I; Hossain A; Kuo MT
    Mol Pharmacol; 2008 Sep; 74(3):823-33. PubMed ID: 18556457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy.
    Chen HH; Kuo MT
    Met Based Drugs; 2010; 2010():. PubMed ID: 20885916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic basis for overcoming platinum resistance using copper chelating agents.
    Liang ZD; Long Y; Tsai WB; Fu S; Kurzrock R; Gagea-Iurascu M; Zhang F; Chen HH; Hennessy BT; Mills GB; Savaraj N; Kuo MT
    Mol Cancer Ther; 2012 Nov; 11(11):2483-94. PubMed ID: 22914438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals.
    Liang ZD; Long Y; Chen HH; Savaraj N; Kuo MT
    J Biol Inorg Chem; 2014 Jan; 19(1):17-27. PubMed ID: 24132751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming platinum drug resistance with copper-lowering agents.
    Chen HH; Kuo MT
    Anticancer Res; 2013 Oct; 33(10):4157-61. PubMed ID: 24122978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic comparison of human high-affinity copper transporter 1-mediated transport between copper ion and cisplatin.
    Liang ZD; Stockton D; Savaraj N; Tien Kuo M
    Mol Pharmacol; 2009 Oct; 76(4):843-53. PubMed ID: 19570948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells.
    Song IS; Savaraj N; Siddik ZH; Liu P; Wei Y; Wu CJ; Kuo MT
    Mol Cancer Ther; 2004 Dec; 3(12):1543-9. PubMed ID: 15634647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A re-evaluation of the role of hCTR1, the human high-affinity copper transporter, in platinum-drug entry into human cells.
    Ivy KD; Kaplan JH
    Mol Pharmacol; 2013 Jun; 83(6):1237-46. PubMed ID: 23543413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The subunits of glutamate cysteine ligase enhance cisplatin resistance in human non-small cell lung cancer xenografts in vivo.
    Fujimori S; Abe Y; Nishi M; Hamamoto A; Inoue Y; Ohnishi Y; Nishime C; Matsumoto H; Yamazaki H; Kijima H; Ueyama Y; Inoue H; Nakamura M
    Int J Oncol; 2004 Aug; 25(2):413-8. PubMed ID: 15254739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal ovarian upregulation of glutamate cysteine ligase expression in response to suppression of glutathione by buthionine sulfoximine.
    Hoang YD; Avakian AP; Luderer U
    Reprod Toxicol; 2006 Feb; 21(2):186-96. PubMed ID: 16183247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the methionines and histidines in the transmembrane domain of mammalian copper transporter 1 in the cellular accumulation of cisplatin.
    Larson CA; Adams PL; Blair BG; Safaei R; Howell SB
    Mol Pharmacol; 2010 Sep; 78(3):333-9. PubMed ID: 20519567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The modifier subunit of glutamate cysteine ligase relates to cisplatin resistance in human small cell lung cancer xenografts in vivo.
    Nishi M; Abe Y; Fujimori S; Hamamoto A; Inoue Y; Miyazaki N; Oida Y; Ikoma N; Ohnishi Y; Yamazaki H; Ueyama Y; Nakamura M
    Oncol Rep; 2005 Aug; 14(2):421-4. PubMed ID: 16012725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin B6 metabolism influences the intracellular accumulation of cisplatin.
    Galluzzi L; Marsili S; Vitale I; Senovilla L; Michels J; Garcia P; Vacchelli E; Chatelut E; Castedo M; Kroemer G
    Cell Cycle; 2013 Feb; 12(3):417-21. PubMed ID: 23287530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy.
    Chen HH; Chen WC; Liang ZD; Tsai WB; Long Y; Aiba I; Fu S; Broaddus R; Liu J; Feun LG; Savaraj N; Kuo MT
    Expert Opin Ther Targets; 2015; 19(10):1307-17. PubMed ID: 26004625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of 6-(methylsulfinyl)hexyl isothiocyanate for sensitization of tumor cells to antitumor agents in combination therapies.
    Yamaguchi H; Kidachi Y; Kamiie K; Noshita T; Umetsu H; Fuke Y; Ryoyama K
    Biochem Pharmacol; 2013 Aug; 86(4):458-68. PubMed ID: 23791871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of glutamate-cysteine ligase protects human COV434 granulosa tumour cells against oxidative and gamma-radiation-induced cell death.
    Cortes-Wanstreet MM; Giedzinski E; Limoli CL; Luderer U
    Mutagenesis; 2009 May; 24(3):211-24. PubMed ID: 19153097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the N-terminus of mammalian copper transporter 1 in the cellular accumulation of cisplatin.
    Larson CA; Adams PL; Jandial DD; Blair BG; Safaei R; Howell SB
    Biochem Pharmacol; 2010 Aug; 80(4):448-54. PubMed ID: 20451502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the human high-affinity copper transporter in copper homeostasis regulation and cisplatin sensitivity in cancer chemotherapy.
    Kuo MT; Fu S; Savaraj N; Chen HH
    Cancer Res; 2012 Sep; 72(18):4616-21. PubMed ID: 22962276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells.
    Goto S; Yoshida K; Morikawa T; Urata Y; Suzuki K; Kondo T
    Cancer Res; 1995 Oct; 55(19):4297-301. PubMed ID: 7671239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.